After Hours Summary: GBR +36% and SHIP +27% higher following earnings/guidance, PRTK +32% on Phase 3 trial update... KATE -9% as sale talks drag on, URBN -3% on negative QTD comps updateAfter Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: GBR +36.2% (also files to delay its 10-K - additional time is required for the proper XBRL review process to be completed), SHIP +27.3%
Companies trading higher in after hours in reaction to news: PRTK +31.5% (reports 'positive' Phase 3 study of Omadacycline in community-acquired bacterial pneumonia), CYCC +19.3% (following 60%+ move higher today), BNTC +11.4% (continued strength), TXMD +3.8% (presents 'positive' safety and efficacy results from its Phase 3 data in two presentations for TX-001HR at ENDO), TEVA +2.4% (announces FDA approval of AUSTEDO tablets for the treatment of chorea associated with Huntington's disease)
After Hours Losers:
Companies trading lower in after hours in reaction to sales update: URBN -2.8% (discloses thus far during the first quarter, comparable retail segment net sales are mid single-digit negative)
Companies trading lower in after hours in reaction to news: KATE -8.8% (lower on reports of sales process being extended as negotiations continue), DGLY -4.7% (files for 800K share common stock offering by stockholders issuable upon the exercise of Common Stock Purchase Warrants), PIR -4.2% (appoints Alasdair James as President and CEO effective start date of May 1, 2017), NMFC -3.3% (commences underwritten offering of 5 mln shares of common stock; provides preliminary estimate of net asset value per share as of March 31), NVCR -1.8% (modestly lower after ~40% move higher today), PN -1.8% (light volume; to delay the filing of its Annual Report on Form 10-K for the year ended December 31, 2016; audit committee commences internal review regarding certain accounting matters)
